-
Niti-S™ NAGI™ Stent_Author Discussion Series : Natsuyo Yamamoto
Natsuyo Yamamoto, MD, PhD, from The University of Tokyo writes about her article“Preliminary report on a new, fully covered, metal stent designed for the treatment of pancreatic fluid collections.” Although efficacy of endoscopic cystogastrostomy for pancreatic fluid collections is reported, few stents dedicated for this purpose are commercially available. We evaluated a newly developed, short metal stent with wide lumen diameter customized for cystogastrostomy in 9 cases. Technical success rate was 100% without early adverse events. Direct endoscopic necrosectomy through the stent was successful in all 3 attempted cases. Stent removal was achieved without difficulties in all 6 cases. THE NEW FULLY COVERED METAL STENT (NAGI STENT, TAEWOONG-MEDICAL CO, LTD, YEONGGI-DO, KOREA) The placement of this metal stent in the treatment of pancreatic fluid collection may prevent complications such as migration and peritonitis. A wide stent lumen enables direct endoscopic necrosectomy through the stent.A plastic stent has been commonly used for enterocystostomy. Endoscopic treatment for pancreatic fluid collection including necrosectomy is technically feasible using this new metal stent. The safety, efficacy, and indication should be evaluated in larger prospective studies.Read the abstract for this article here.The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
Niti-S™ KAFFES™ Stent_ Author Discussion Series: Ken Liu
Ken Liu, Faculty of Medicine at the University of Sydney in Camperdown, New South Wales, Australia, reports on his Review Article“Fully covered self-expandable metal stents for treatment of benign biliary strictures.” The focus of this paper was the use of fully covered self-expandable metal stents (FCSEMS) in the treatment of benign biliary strictures (BBSs). There has been an explosion of recent research on the use of FCSEMSs in BBSs with suggestions of a paradigm shift from using plastic stents. Due to their growing popularity, we felt it was important to review the available literature on the efficacy, safety, and cost-effectiveness of FCSEMSs in BBSs.FCSEMSs have been shown to achieve excellent success rates in both transplant and non-transplant BBSs (>90% in some studies). This success is sustained for over 12 months in most studies. The efficacy of FCSEMSs is unchanged when used as first-line or as second-line therapy (after balloon dilation and plastic stenting). The subset of patients with BBSs secondary to chronic pancreatitis remains a challenge (46-75% success). Results of FCSEMSs in BBSs are similar to studies of plastic stents, in particular, studies using multiple plastic stents. Fewer ERCP sessions are required for treatment of BBSs with FCSEMSs which may result in cost savings, although published data are lacking. Figure 1. A, An example of the classic stent type (Bonastent; Standard Sci-Tech). B, An example of a new stent type (Niti-S Kaffes; Taewoong). The stent sits entirely within the biliary tree with a long removal string that rests in the duodenum. The antimigration feature in this stent is the gradual tapering in the middle of the stent FCSEMSs are safe to use. Adverse events such as pancreatitis, cholangitis, secondary strictures, and pain are infrequent and usually respond to conservative management. Spontaneous stent migration rates are variable; however, several anti-migration modifications have demonstrated efficacy in reducing this adverse event.There is still a need for further studies, in particular, randomized controlled trials comparing FCSEMSs vs. plastic stents. Data are also lacking regarding optimal duration of stent placement, and the cost effectiveness and long term safety of FCSEMSs.Read this article on pages 13-21 of the print Journal or find it online.The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
UVENTA™_2nd Meeting of the EAU Section of Urolithiasis stent procedure Live
한덕현 교수, 유럽서 요관스텐트 라이브수술 시연덴마크 코펜하겐 학회에서 유벤타 스텐트 주제로 시연 및 강의기사입력시간 : 2013-09-26 11:08:39최종편집시간 : 2013-09-26 11:08:39이혜선 기자 [청년의사 신문 이혜선]성균관의대 삼성서울병원 비뇨기과 한덕현 교수가 지난 3~7일 5일간 덴마크 코펜하겐에서 열린 EAU(유럽비뇨기과학회) 주관, 요로결석학회 및 수술 워크숍(2nd Meeting of the EAU Section of Urolithiasis(EULIS))에서 유벤타 스텐트(Uventa stent)라는 주제로 라이브수술 및 강의를 시행했다.3일 열린 수술 워크숍(surgical workshop)에서는 네 종류의 요관용 금속스텐트에 대한 강의 및 라이브 수술이 시연됐다.한덕현 교수는 라이브 수술자로 참석하여 새로 개발된 이중금속커버스텐트에 대한 논문(Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (Uventa™) in malignant ureteral obstructions) 및 임상경험을 소개했으며 악성종양으로 인한 요관폐색 환자에게 성공적으로 수술을 시연해 참가 의료진들로부터 주목을 받았다.한덕현 교수는 “요관협착은 타장기에 비해 금속스텐트의 적용이 늦게 시작된 분야로서, 기구의 발전과 임상경험의 축적이 절실한 상태”라며 “삼성서울병원에서는 이미 보편화된 수술 경험이, 이제 시작하는 유럽의 의사들에게는 많은 관심을 유발한 것 같다”고 소감을 밝혔다.EULIS는 유럽비뇨기과학회(EAU)에서 결석 및 비뇨내시경 관련 학술모임을 활성화하고자 만든 세부학회로 올해로 2회째를 맞고 있다. 금번 학회는 유럽의 요로결석 전문가 300여 명이 참석한 가운데 개최됐다.http://www.docdocdoc.co.kr/news/newsview.php?newscd=2013092600007
16.03.19 -
UVENTA™ EAU Report_The future of metal stenting at EULIS Pre-meeting Symposium
Leading off the 2nd EULIS Meeting in Copenhagen was a special pre-conference symposium on metal stenting of the ureter on September 4th. This special event took place in the Copenhagen University Hospital, the Rigshospitalet, and featured live surgery demonstrations. Mr. Noor Buchholz was key in bringing together all four companies producing metal stents for the first time. “About two years ago, I had a vision for bringing together the four companies involved in the development and production of metal stents. As the EULIS Section meeting was approaching, we decided to piggy-back the stent workshop as a pre-meeting symposium,” Buchholz explained.“Metal stents are very much a niche market, so I think it’s more important for the companies to work together to spread awareness of these products, rather than compete for a small target audience. I’m trying to raise awareness of the use of metal stents in urology, because I think they are very useful for the “right” patients.”Mr. Buchholz points out two major problems of preconceptions about metal stenting. “We’ve seen metal stents in the past that simply didn’t work, so older urologists won’t touch them. The second problem is related: younger urologists aren’t being taught about them, and might not even be familiar with them.”According to Buchholz, this newer generation of stents, as developed in the past ten years has one key advantage over the older models: they are much easier to place and remove, which can be done through minimally invasive surgery. The biggest advantage compared to contemporary competitors like the double-J stent is their longevity:“The initial purchase price is considerably higher, but because the stents do not have to be replaced two or three times per year like plastic stents, the patient requires less surgery, making it cost-neutral in the first year. From the second year onward, it’s an annual saving of some €5000 per patient. And the patient won’t have to undergo regular surgery, with all of the disadvantages thereof. It’s a great solution for patients who need long-term stenting. One of my patients has had a stent for 80 months now.”The four companies involved in the symposium were PNN Medical with its Memokath thermolabile nitinol stent, Cook Medical with its grooved metal double-J Resonance stent, Allium with its self-expanding polyurethane stent, and Taewoong with its Uventa Ureteral Stent, another self-expanding stent. The live surgery demonstrations were given for each of the four companies’ stents.Other presentations at the symposium showed the current state of developments, techniques for placement and maintenance, as well as a look into the future of metal stents. Biocompatibility and biodegradability are two important properties for improved treatment of patients. Other innovations are the antibody-coated stents, nanotube coating and radioactive stents for internal treatment. An absorbable magnesium metal stent is to combine the inertness of biomaterial with the stability of a metal.
16.03.19 -
Niti-S™ SPAXUS™ Stent_Metal stents for lumen apposition for EUS-guided drainage
Metal stents for lumen apposition for EUS-guided drainageJong Ho Moon, MD from the Digestive Disease Center and Research Institute at SoonChunHyang University School of Medicine in Bucheon/Seoul, South Korea discusses this New Methods article “A newly designed fully covered metal stent for lumen apposition in EUS-guided drainage and access: a feasibility study (with videos)” from the June issue. EUS-guided transenteric drainage by using a newly developed fully covered metal stent that is capable of lumen apposition was successfully performed in animal study and small sized clinical experiences. This stent is equipped in conventional delivery system, and preventive for migration and leak because of backwardly folded flanges in both ends and full covering of stent.As EUS-guided therapeutic interventions have evolved, development of metal stents for safe and effective procedures is needed.The EUS-guided drainage was successfully performed by using the new stent. There were no adverse events such as migration or leakage. Endoscopic interventions through the stent was immediately possible, and the stents were easily removed after 4 weeks in patients with pancreatic pseudocyst. Large scaled clinical studies are warranted.Additional expected usage of this new stent is choledochoduodenostomy or temporary insertion into the gallbladder for formation of an access route to perform endoscopic interventions.Read the article abstract here. Figure 1. A, A new fully covered metal stent having folding-back wide anchoring flanges for lumen apposition. B, A 10F conventional delivery system with a constrained stent The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
Niti-S™ NAGI™ Stent_Management of pancreatic collections with novel stent
Dr. Sujievvan Chandran from the Department of Gastroenterology, Austin Health Melbourne in Victoria, Australia discusses his Original Article“Management of pancreatic collections with a novel endoscopically placed fully covered self-expandable metal stent: a national experience (with videos).” The purpose of this study was to evaluate a recently developed lumen-apposing, fully covered self-expandable metal stent (FCSEMS) in the management of pancreatic fluid collections (PFCs).The recent literature indicates that endoscopically inserted FCSEMSs may be superior to traditional plastic stenting in the management of PFCs. However, the current literature is limited by small case series undertaken by single operators, across expert centers, and by the use of tubular stents not specifically designed for the management of PFCs. We therefore undertook a multicenter study to address the deficiencies in the current literature. Figure 1. The novel lumen-apposing stent with flared ends to prevent migration and drawstring attachment located at the gastric end to aid extraction We recruited 54 stent cases across 13 centers throughout Australia. Successful insertion occurred in 53/53 (98.1%) with the majority (88.9%, 48/54) being described as easier to insert by the operator in comparison to plastic stenting.This relates to the fact that multiple plastic stenting can be technically more demanding with the associated increased procedural time compared to a single FCSEMS insertion. Stent extraction was also described as superior to plastic stent extraction in the majority of cases (88.6%, 31/35), which can be attributed to the stent design where a draw string at the gastric flange end facilitates rapid collapse and extraction of the stent. The PFC resolution rate in our cohort (76.6%) corresponds to the lower end of what is published in the available literature. We feel that this reflects a real-world experience given the number of centers involved in addition to a larger subgroup of patients with walled of pancreatic necrosis and infected pseudocysts which traditionally have lower resolution rates.Direct endoscopic necrosectomy, while not universally successful across our cohort, did provide a bridge to surgery in a substantial proportion of our patients who were stabilized from a sepsis point of view post FCSEMS insertion which resulted in improvements in the clinical state prior to surgical intervention. Commonly observed adverse events included stent migration (spontaneous and during direct endoscopic necrosectomy [DEN]), recurrent stent occlusion and tissue ingrowth/overgrowth. Stent migration was likely due to the fact that rapid cyst decompression may overcome the anchoring flared ends. Similarly, during DEN the force placed on the stent via the movement of the endoscope overcame the flared end resulting in dis-lodgement into the stomach. Long term stent placement resulted in cases of stent ingrowth related to loss of the silicone coating and overgrowth which indicate that it may not be suitable for the management of PFCs that require long term stenting (eg, disconnected pancreatic tail syndrome).While we have shown a real world experience of PFC management with this novel FCSEMS, randomized control studies are required to further evaluate the benefit of FCSEMS over pigtail stents.Read the abstract for this article online.The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
Niti-S™ NAGI™ Stent_EUS-guided drainage using metal stents
Ryosuke Tonozuka, MD, from the Depatment of Gastroenterology and Hepatology at Tokyo Medical University in Tokyo, Japan discusses this New Methods article“EUS-guided drainage of hepatic abscess and infected biloma using short and long metal stents (with videos).” Refractory hepatic abscess (HA) and infected biloma (IBL), in which inflammation does not improve only by the dosage of the antibiotic agent, often require percutaneous drainage (PCD) and surgical interventions. Recently, the usefulness of EUS-guided hepatic abscess drainage (EUS-HAD) and US-guided biloma drainage (EUS-BLD) has been described. However, there has been only 1 report of a case in which a fully covered self-expandable metal stent (FCSEMS) was used. In this study, we evaluated the safety and efficacy of EUS-HAD and EUS-BLD using a FCSEMS retrospectively.We used 2 types of FCSEMSs for the drainage. If the target lesion was close to the digestive tract (≤2 cm), a short biflanged FCSEMS (short stent; 16 mm in diameter, 2 or 3 cm in length) was used. If the target lesion was far (≥3 cm), a conventional biliary FCSEMS (long stent; 8 or 10 mm in diameter, 6 or 8 cm in length) was used. Figure 1. Schema of EUS-guided drainage of HA using a short and large diameter biflanged self-expandable metal stent (short SEMS) The technical success rate was 100% and the clinical success rates of EUS-HAD and EUS-BLD at the first session were 71.4% and 83.3%, respectively. In 2 cases, they needed necrosectomy (endoscopic necrotic tissue removal) as an additional therapy. The final clinical success rate was 100%. There were no procedure-related adverse events and no cases of recurrence during the follow-up period (median, 83.5 days).We think EUS-guided drainage has several advantages over PCD as follows: 1) one-step internal drainage is suitable for patients not only for cosmetic reasons but also for physiologic liquid flow; 2) there is no risk of self-removal of the external drain, which causes peritonitis; 3) possible drainage of the lesion around the caudate lobe where puncture may be difficult. Furthermore, a 10-mm-diameter fully covered or 16-mm-diameter fully covered self-expandable metal stent (SEMS) may have several advantages compared with 1 or more conventional PS for treatment by EUS-HAD and EUSBLD as follows: 1) only 1 stent is required because of the large diameter; thus, FCSEMS placement may allow fewer sessions and reduce the procedure time; 2) minimum leakage of liquid in the cavity; 3) upon FCSEMS placement, sufficient drainage is expected, leading to rapid improvement; 4) DEN can be easily performed through the large-bore stent, as was seen in this study, as DEN was easily performed through the FCSEMS in 2 cases; and 5) FCSEMSs may be helpful for hemostasis when unexpected bleeding from the tract occurs during the procedure. Figure 2. Schema of EUS-guided drainage of biloma using a usual long biliary self-expandable metal stent (long SEMS) The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
Niti-S™ NAGI™ Stent_Pulsating pseudoaneurysm in a walled-off necrosis
Shuntaro Mukai from the Department of Gastroenterology and Hepatology at Tokyo Medical University in Tokyo, Japan describes this VideoGIE case “Pulsating pseudoaneurysm in a walled-off necrosis.” Our video case describes a pulsating pseudoaneurysm in the cavity of a walled-off necrosis (WON) diagnosed by endoscopy through a fully-covered biflanged metal stent (BFMS). Subsequently, the pseudoaneurysm was successfully treated. A 38-year-old man developed an infected WON after severe necrotizing pancreatitis. A novel BFMS (16 mm in diameter and 20 mm in length) was placed under EUS guidance. Then, direct endoscopic necrosectomy (DEN) was performed through the BFMS. Seven days after DEN, he vomited blood; we suspected bleeding from the cavity. Emergency angiography was not able to detect any obvious bleeding point. After seven days of conservative therapy, an endoscope was advanced to examine the condition within the cavity. Surprisingly, a pulsating pseudoaneurysm was found. Subsequently, the pseudoaneurysm was treated by coil embolization. Interestingly, a “second-look” endoscopy determined that the pseudoaneurysm completely resolved after use of the embolization coil.To the best of our knowledge, this is the first video which shows a pulsating pseudoaneurysm detected by direct endoscopic imaging and subsequently successfully treated by coil embolization. Bleeding from the cavity due to the rupture of a pseudoaneurysm is a fatal complication in patients with WON. Thus, the management of bleeding is mandatory for treatment success.BFMS is useful for the treatment of WON also in that observation in the cavity of WON by endoscopy can be easily performed during the treatment course.Find more VideoGIEs available online. Figure 1. Endoscopic imaging revealed a pulsating pseudoaneurysm (A). A “second-look” endoscopy demonstrated that the pseudoaneurysm completely resolved after use of the embolization coil (B). Angiography revealed a pseudoaneurysm (C), which was subsequently treated by coil embolization (D). The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
Niti-S™ Eso.TTS Stent_Hemorrhagic pancreatic necrosis drainage
Prashant Kedia, MD from the Division of Gastroenterology and Hepatology, Weill Cornell Medical College at Cornell University in New York, New York, USA shares this video case “Hemorrhagic pancreatic necrosis drainage by using an esophageal stent.” This video highlights the case of a patient with infected hemorrhagic pancreatic necrosis treated with endoscopic debridement through a fully covered metal esophageal stent. Initially, double pigtail plastic stents were placed due to the fluid nature of the contents. However due to an acute bleeding event into the collection possibly secondary to a pseudoaneurysm, the patient developed hemorrhagic pancreatic necrosis which subsequently became infected. To endoscopically manage this situation, direct necrosectomy was required via EUS-guided placement of a fully covered metal esophageal stent with through-the-scope deployment into the walled-off hemorrhagic pancreatic necrosis. Through this multiple techniques for debridement including usage of snares and nasocystic drains were applied to evacuate the cavity. This video is useful to portray the advantage of using fully covered metal stents for walled off pancreatic necrosis compared to plastic stents. Due to large lumenal diameter of these metal stents, they allow for direct endoscopic necrosectomy and removal of large solid material. Although only one metal stent is currently approved for pseudocyst drainage in the United States, fully covered, through-the-scope esophageal stents can also be used in these situations.The application of EUS-guided cystgastrostomies with fully covered metal esophageal stents have been shown in prospective case series to allow for successful endoscopic necrosectomy of walled off pancreatic necrosis. These stents allow for maintenance of a gastrocystic fistula through which multiple necrosectomy sessions can be performed and a nasocystic drain can be placed for continuous flushing.Find more VideoGIEs available online.The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
Niti-S™ Eso.TTS Stent_EUS-Guided Drainage of Pseudocyst_USA
Payal Saxena, MD, from the Department of Medicine, Division of Gastroenterology and Hepatology at Johns Hopkins Hospital in Baltimore, Maryland, USA presents this video case “EUS-Guided Drainage of a Giant Hemorrhagic Pseudocyst by a Through-the-scope Esophageal Metal Stent.” A 78-year-old man with hemorrhagic transformation of a 17cm pseudocyst was hemodynamically unstable requiring splenic artery embolization. He developed gastric outlet obstruction due to the pseudocyst, which was then drained under EUS guidance by creating a cystgastrostomy, flushing the cavity with hydrogen peroxide and placement of a through-the-scope, covered esophageal metal stent (18mm x 60mm) across the cystgastrostomy. A total of 2.4L of blood was drained during the procedure. The patient experienced a rapid resolution of symptoms post-procedure. At 4 week imaging, the pseudocyst had completely resolved after a single procedure. The stent was easily removed with a snare at follow-up endoscopy.We have demonstrated a novel technique which facilitates safe and rapid resolution of a giant pseudocyst with large volume solid debris (blood clots) without the need for repeated endoscopic procedures, debridement or external drainage. Hydrogen peroxide facilitated dissolution of the blood clots. The wide bore stent allowed passage of debris from the pseudocyst cavity without becoming clogged. The wide caliber covered metal stent also ensured complete seal of the cystgastrostomy tract, preventing complications of leaks and perforation.Wide bore fully covered metallic stents can be safely used for drainage of pancreatic fluid collections which contain a large volume of solid debris.Watch the video here. Figure 1. Fluoroscopic image of the fully covered self expandable metallic stent placed across the cystgastrostomy. A double pigtail stent is seen within the metallic stent. Splenic artery embolization coil is seen to the left of the stent The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
2012 Newsletter_Novel and innovative stents for EUS-guided drainage 16.03.19
-
2012 Newsletter_ New products_ Biliary short wire system & Beta esophageal stent 16.03.19
-
Niti-S™ KAFFES™ Stent _Editor's Choice - Stuart Sherman
Associate Editor, Stuart Sherman, MD, FASGE, recommends the article“Fully covered self-expandable metal stents for the treatment of benign biliary strictures”by Arthur J. Kaffes, MBBS, FRACP and Ken Liu, MBBS, BSci (Med) from the July issue of GIE. This review article highlights the use of fully covered self-expandable metal stents (FCSEMSs) as a potential paradigm shift in our management of benign biliary strictures.This review is well-written and is encyclopedic in summarizing the world’s literature on the performance, clinical utility, and safety of FCSEMSs for the treatment of benign biliary strictures. As an evolving area of investigation, this is a very timely review. Figure 3. These fluoroscopic images illustrate one of the newer intraductal fully covered self-expandable metal stent type used in a 53-year-old woman with an anastomotic stricture after orthotopic liver transplantation (OLT). A, Cholangiogram clearly demonstrating a tight anastomotic stricture post-OLT. B, The FCSEMS (Niti-S Kaffes; Taewoong) is inserted across the stricture and is entirely within the biliary tree. C, The stent is seen in situ with the radiopaque removal string seen clearly in the duodenum (white arrow). D, The stricture has completely resolved. There are limited data on the use of FCSEMS and only 1 small RCT published as an abstract. Based on these limited data, it would appear that:Placement of FCSEMSs in the treatment of benign biliary strictures is feasible and effective in both the post-transplant and non-transplant settings as a first or second line therapy.Similar success rates occur with the plastic stents; however, since FCSEMSs require fewer endoscopic sessions to achieve clinical success, they will likely be cost effective.It appears that the complication rates of plastic stents and FCSEMSs are similar.FCSEMSs are currently not approved by the FDA for the indication of benign biliary strictures in the USA.Further prospective randomized trials are needed to assess efficacy of FCSEMSs compared with plastic stents and their long-term safety and cost-effectiveness before routine use can be recommended for benign biliary strictures.Read this article on pages 13-21 in the print journal or find it online.The information presented in Endoscopedia reflects the opinions of the authors and does not represent the position of the American Society for Gastrointestinal Endoscopy (ASGE). ASGE expressly disclaims any warranties or guarantees, expressed or implied, and is not liable for damages of any kind in connection with the material, information, or procedures set forth.
16.03.19 -
CONNECT GLOBAL issue 6 / OCT 2015 15.11.04
-
United European Gastroenterology 2015
Connect Global We have been issuing annual publication “Connect Global” since 2012. It is composed of TW performances, Scientific update, Product update. In this year, Connect Global contains interviews with Prof.Moon and Prof.Laleman regarding SPAXUS™ and ELRA™.Please follow the link as below.http://stent.net/connect-global-issue-6-oct-2015/ Taewoong Medical in UEGW 2015 ● Oct 26~28, 2015● Congress venue: Fira Barcelona Gran via, Spain● Booth Exhibition & Taewoong Medical Events We have participated in various International conferences. UEGW 2015 (The United European Gastroenterology) is the most valuable world congress of Gastroenteology that we participate. The UEGW booth was designed in order to maximize visitor conveniences by having large display tables, sofas and phone charging station mounted tables. In particular, Endoscopic RFA products were introduced and received significant attention by Key opinion leaders.Before UEGW exhibition, we organized Partner’s day with our exclusive distributors from all over the world. We had discussions about marketing and product updates, new published articles, abstracts and current company issues.Especially we invited Prof. Moon who is inventor of SPAXUS™, and had a product insight session included introduction of SPAXUS™, QnA regarding EUS procedure. Mr. Kakuno from Japan presented sales approach strategy with his experiences. Through this annual meeting, we’re looking forward to meaningful discussion included your ideas, opinions about businesses and our further improvements.One of the most important annual event The 5th Niti-S™ Dinner Symposium was held at Crowne plaza, Fira center. Dr. D Reddy (India) and Dr. Garcia (Spain) thankfully joined us as moderator in spite of their busy schedule, and almost 150 guests.
15.11.04 -
Digestive Disease Week 2015
Digestive Disease Week 2015 ● May 17~19, 2015● Congress Venue: Walter E.Conventioncenter, Washington D.C, USA● Booth Exhibition & Taewoong Medical Events We have participated in various International conferences. DDW is the most valuable world congress of Gastroenteology that we participate. The DDW booth was designed in order to maximize visitor conveniences by having multi entrances, sofas and phone charging station mounted tables. In particular, Newly released ‘Enteral Comvi™ stent was introduced and installed Lucky Draw event in order to create customer interests. Before DDW exhibition, we organized Partner’s day with our exclusive distributors from all over the world. We had discussions about marketing and product updates, new published articles, abstracts and current company issues. Mr. gurpp from Germany and Mr. Enrico from Italy presented their experiences about NAGI™, large diameter Esophageal stent and BETA™ stent. One of the most important event NiTi-S™ Dinner party was held at Howard theatre. Almost 180 guests from all around the world were accompanied by live music and fabulous dinner.Upcoming DDW 2016 is going to be held at San Diego, USA. We always welcome you to join TW program and visit our booth.
15.06.01